3D Cell Culture Conference

SMi’s fifth annual 3D Cell Culture Conference 

Conference Co-Chairs: Stefan Przyborski, Professor of Cell Technology at Durham University (UK) and Philip Hewitt, Global Head of Early Investigative Toxicology at Merck (Darmstadt, Germany). 

Sponsored by: CELLINK (MA, US), CelVivo (Blommenslyst, Denmark), Promega (WI, US) and Newcells Biotech (Newcastle, UK). 

Background: 

3D cell culture is gaining momentum in the pharmaceutical industry on account of the advantages such models pose in drug discovery, from improved clinical translation to patient safety and sustainability. 

SMi’s 3D Cell Culture Conference will explore advances in the application of 3D cell models, from their employment in drug screening to reduce candidate attrition, to the latest insights into microphysiological systems, the regulatory landscape and the clinical applications of 3D bioprinting. 

Two interactive workshops on 8th February 2022: 

Workshop A: Reducing attrition in drug discovery through the utilization of human translational cellular models. 

Workshop Leader: Wendy Rowan, Scientific Director in Novel Human Genetics at GSK (London, UK). 

Workshop B: Bioprinting for 3D Cell Culture. 

Workshop Leader: Kenny Dalgarno, Professor of Manufacturing Engineering at Newcastle University (UK). 

Key benefits of attending: 

• Discuss the potential of advanced cell technologies to construct in vitro models of human tissues 
• Explore the regulatory sciences surrounding microphysiological systems and their development and adoption for drug safety assessment 
• Uncover the major benefits of 3D modeling in enhancing clinical translation and predictability 

• Utilize 3D cell culture for high-throughput drug discovery and content screening over traditional 2D methods 
• Delve into advanced case studies looking into organ models, from organotypic lungs to liver spheroids 

Who should attend? 

• Biotech and pharma company professionals 
• Academic professors in cell technology, stem cell sciences, biochemistry, protein technology and tissue engineering 
• Solution providers 
• Organizations/regulatory professionals 

Find out more>>